ARCHIVES

Two Phase II Ibrutinib Studies Presented to EHA Demonstrate Efficacy as a Monotherapy

This article is from The Cancer Letter archive.

Vol. 36 No. 7 | July 26, 2013

Download PDF Visit The Full Archive

Related Articles

NCA Urges Pay Line Adjustment To Cut Back On Grant Duplications

October 10, 1980

Report calls for stronger peer review, prioritization for cancer clinical trials.

June 10, 2005

Program Announcement; NCI Seeks Studies Of Breast Cancer In Northeast U.S.

January 22, 1993

Drugs and Targets: Cyramza approved in metastatic stomach cancer

November 7, 2014

FDA Oncologic Drug Committee Agrees That “Kitty Fight” With NCI Should Be Negotiated

November 28, 1975

Lasagna Committee Urges Medicare Payment for Experimental Drugs, Care

September 29, 1989